Hydrogenology
Source-linked study record

Protective effect of hydrogen-rich saline on ischemia/reperfusion injury in rat skin flap

Zhao L, Wang YB, Qin SR, Ma XM, Sun XJ, Wang ML, Zhong RG. · Journal of Zhejiang University Science B. 2013;14(5):382-391.

PreclinicalOther formsPublished 2013Source checked
Study record, not medical adviceThis record reports what the source states. It is not medical advice and does not establish that molecular hydrogen is effective, safe or appropriate for any person.
Quick summary

Study at a glance

Evidence type

Preclinical

Population or model

Sixty male Sprague-Dawley rats with abdominal epigastric skin flaps exposed to three hours of vascular occlusion and reperfusion.

Intervention and dose

A single intraperitoneal H₂-rich saline injection of 5 or 10 mL/kg, ten minutes before reperfusion. · H₂ was dissolved for six hours at 0.4 MPa; freshly prepared weekly H₂-rich saline was maintained above 0.6 mmol/L.

Duration

Single dose before reperfusion; acute perfusion was followed for three hours and flap survival, perfusion, histology and biomarkers were assessed on postoperative day 5.

Reported result

Both H₂-rich-saline doses improved flap survival, day-5 perfusion and inflammatory/oxidative measures versus saline. Day-5 perfusion did not differ significantly between 5 and 10 mL/kg, solution pH did not differ from saline, and RANTES was the reported cytokine exception. Perfusion during the three-hour occlusion did not differ among operative groups.

Main limitation

Preclinical flap model, single pre-reperfusion dose, five-day follow-up, multiple surrogate and cytokine endpoints, and no comparison with standard reconstructive-surgery measures. Beijing Natural Science Foundation support was reported; authors declared no conflicts.

Evidence and classification

What kind of evidence is this?

Evidence type

Preclinical

Reported design

Randomized four-group rat skin-flap dose-comparison experiment

Research topic

Skin, wound and aging research

Administration form

Other forms

Information not yet classified

Some editorial classification fields are still pending. The source-reported outcomes and result are shown below; Hydrogenology does not infer a positive or negative signal from prose automatically.

Reported in the source

Methods

Population or model

Sixty male Sprague-Dawley rats with abdominal epigastric skin flaps exposed to three hours of vascular occlusion and reperfusion.

Sample

60 rats randomized equally to sham, ischemia/reperfusion plus saline, I/R plus 5 mL/kg H₂-rich saline, or I/R plus 10 mL/kg H₂-rich saline, n=15 each.

Duration

Single dose before reperfusion; acute perfusion was followed for three hours and flap survival, perfusion, histology and biomarkers were assessed on postoperative day 5.

Intervention

A single intraperitoneal H₂-rich saline injection of 5 or 10 mL/kg, ten minutes before reperfusion.

Hydrogen form

H₂ dissolved in normal saline — H₂ only, not Brown's gas.

Dose or H₂ specification

H₂ was dissolved for six hours at 0.4 MPa; freshly prepared weekly H₂-rich saline was maintained above 0.6 mmol/L.

Comparator

Sham surgery and ischemia/reperfusion with 5 mL/kg ordinary saline, plus 5 versus 10 mL/kg H₂-rich saline.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Tissue H₂ concentration, flap survival area, laser-speckle perfusion, histology/inflammatory infiltration, MDA and a multiplex cytokine panel.

Reported result

Both H₂-rich-saline doses improved flap survival, day-5 perfusion and inflammatory/oxidative measures versus saline. Day-5 perfusion did not differ significantly between 5 and 10 mL/kg, solution pH did not differ from saline, and RANTES was the reported cytokine exception. Perfusion during the three-hour occlusion did not differ among operative groups.

Extraction completeness

The complete free PMC article was checked for all four groups, H₂ preparation/concentration, both doses, tissue H₂ measurements, positive and null outcomes, funding and conflict declaration.

A reported association, difference or mechanism is not automatically a clinical benefit.

Interpretation limits

Limitations and applicability

Main methodological cautions

Preclinical flap model, single pre-reperfusion dose, five-day follow-up, multiple surrogate and cytokine endpoints, and no comparison with standard reconstructive-surgery measures. Beijing Natural Science Foundation support was reported; authors declared no conflicts.

Applies directly to

Surgically created skin-flap ischemia/reperfusion in male rats; it does not establish improved human flap survival.

No single-study GRADE certainty rating is assigned. Read how records and evidence assessments are prepared.

Sources and status

Sources and record status

Identifiers

PMID: 23645175 · DOI: 10.1631/jzus.B1200317

Publisher access

Free full article in PubMed Central.

Extraction basis

Complete PMC article and PubMed metadata; full-text extraction checked 9 August 2026.

Last reviewed

10 August 2026

Help the next reader

Help people check the facts before they buy.

Hydrogenology keeps 665 source-checked records accessible without advertising or product promotion.

Support independent access
Help us correct the recordReport a discrepancy

Send the exact difference between this page and the linked source. The study reference is attached automatically.